DETECTION OF METHICILLIN RESISTANCE IN CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS IN TERTIARY CARE HOSPITAL, TIRUPATI
DOI:
https://doi.org/10.22159/ijcpr.2024v16i2.4062Keywords:
Methicillin resistance staphylococcus aureus, Cefoxitin, Staphylococcus aureus, Disc diffusion testAbstract
Objective: The study aimed to estimate the prevalence of methicillin resistance of Staphylococcus aureus in various clinical samples received at tertiary care hospital. Initially, the Staphylococcus aureus and its antibiotic susceptibility tests is performed in clinical samples which are submitted to the department of Microbiology. And Methicillin Resistance Staphylococcus Aureus (MRSA) is determined by using cefoxitin (30 μg) as per CLSI guidelines.
Methods: The prospective study was conducted in department of Microbiology in a tertiary care hospital. All Staphylococcus aureus organisms isolated in clinical samples were included in the study and processed as per the standard operating procedure. Methicillin susceptibility was tested by using cefoxitin (30μg) disks on Muller-Hinton agar plates that were inoculated with a suspension (equal to 0.5 McFarland standards) of the s. aureus.
Results: In our study, amongst hundred staphylococcus aureus isolates, sixty isolates were shown resistance to cefoxitin (30µg), which indicates that percentage of methicillin-resistant s. aureus in our study is 60. Majority of s. aureus were isolated from blood samples 44% (n= 44) followed by pus samples 32% (n=32). Linezolid resistance reported was 3%. All isolates were sensitive to vancomycin and daptomycin by disc diffusion test as per CLSI guidelines 2021.
Conclusion: To conclude, MRSA plays a significant role and it can be transmitted through endogenous, cross-infection and reinfections. Phenotypic methods like use of cefoxitin disc (30µg) can be considered for detection of methicillin resistance in S. aureus, as it consumes less time and easy to perform.
Downloads
References
Colley EW, McNicol MW, Bracken PM. Methicillin-resistant Staphylococci in a general hospital. Lancet. 1965;1(7385):595-7. doi: 10.1016/s0140-6736(65)91165-7, PMID 14250094.
Scragg JN, Appelbaum PC, Govender DA. The spectrum of infection and sensitivity of organisms isolated from African and Indian children in a Durban hospital. Trans R Soc Trop Med Hyg. 1978;72(4):325-8. doi: 10.1016/0035-9203(78)90118-9, PMID 705838.
Geyid A, Lemeneh Y. The incidence of methicillin resistant S. aureus strains in clinical specimens in relation to their beta-lactamase producing and multiple-drug resistance properties in Addis Abeba. Ethiop Med J. 1991;29(4):149-61. PMID 1954949.
Foster TJ. The staphylococcus aureus “superbug”. J Clin Invest. 2004;114(12):1693-6. doi: 10.1172/JCI23825, PMID 15599392.
Gupta K, Martinello RA, Young M, Strymish J, Cho K, Lawler E. MRSA nasal carriage patterns and the subsequent risk of conversion between patterns, infection, and death. Plos One. 2013;8(1):e53674. doi: 10.1371/journal.pone.0053674, PMID 23326483.
Davoodabadi F, Mobasherizadeh S, Mostafavizadeh K, Shojaei H, Havaei SA, Koushki AM. Nasal colonization in children with community acquired methicillin-resistant Staphylococcus aureus. Adv Biomed Res. 2016;5:86. doi: 10.4103/2277-9175.182217, PMID 27274501.
Pathak A, Marothi Y, Iyer RV, Singh B, Sharma M, Eriksson B. Nasal carriage and antimicrobial susceptibility of Staphylococcus aureus in healthy preschool children in Ujjain, India. BMC Pediatr. 2010;10:100. doi: 10.1186/1471-2431-10-100, PMID 21190550.
Lowy FD. Antimicrobial resistance: the example of staphylococcus aureus. J Clin Invest. 2003;111(9):1265-73. doi: 10.1172/JCI18535, PMID 12727914.
Taiwo S, Onile B, Akanbi A II. Methicillin-resistant staphylococcus aureus (MRSA) isolates in Ilorin, Nigeria. Af J Clin Exp Micro. 2004;5(2):189-97. doi: 10.4314/ajcem.v5i2.7376.
Shittu AO, Lin J, Morrison D, Kolawole DO. The discovery of a multi-resistant Staphylococcus haemolyticus clone in the hospital and community environment in south western Nigeria. Ostomy Wound Manage. 2005;51(1):67-70. PMID 15695837.
Forbes BE, Sahm DF, Weissfeld AS, Trevino EA. Baily and scotts diagnostic microbiology. 11th ed. Toronto: CV Mosby Company; 2002.
Clinical and Laboratory Standards Institute, CLSI. Performance Standard for antimicrobial susceptibility for antimicrobial susceptibility testing; Fifteen Informational supplement. CLSI/NCCLS documents M100-S15. USA; 2005.
Skov R, Smyth R, Clausen M, Larsen AR, Frimodt Møller N, Olsson Liljequist B. Evaluation of a cefoxitin 30 microg disc on iso-sensitest agar for detection of methicillin-resistant staphylococcus aureus. J Antimicrob Chemother. 2003;52(2):204-7. doi: 10.1093/jac/dkg325, PMID 12837728.
Velasco D, del Mar Tomas M, Cartelle M, Beceiro A, Perez A, Molina F. Evaluation of different methods for detecting methicillin (oxacillin) resistance in staphylococcus aureus. J Antimicrob Chemother. 2005;55(3):379-82. doi: 10.1093/jac/dki017, PMID 15722394.
Wayne PA. Performance standards for antimicrobial susceptibility testing. fifteenth informational supplement. Vol. S15. Clinical and laboratory standards Institute/NCCLS, CLSI/NCCLS document M100; 2014.
Lu PL, Tsai JC, Chiu YW, Chang FY, Chen YW, Hsiao CF. Methicillin-resistant staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant. 2008;23(5):1659-65. doi: 10.1093/ndt/gfm806, PMID 18029375.
Garrouste Orgeas M, Timsit JF, Kallel H, Ben Ali AB, Dumay MF, Paoli B. Colonization with methicillin-resistant staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use. Infect Control Hosp Epidemiol. 2001;22(11):687-92. doi: 10.1086/501846, PMID 11842988.
Clinical laboratory standard institute 2004. Quality control for commercially prepared microbiological culture media; approved standard. 3rd ed. Vol. A3. Wayne, PA; 2004. p. M22.
CLSI. Performance standards for antimicrobial susceptibility testing. 29th ed. Wayne, PA: Clinical and Laboratory Standards Institute. CLSI supplement M100; 2019.
Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM. Prevalence of methicillin resistant staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol. 2003 Jan-Mar;21(1):49-51. PMID 17642975.
Hanumanthappa AR, Chandrappa NR, Rajasekharappa MG. Prevalence of methicillin resistant Staphylococcus aureus in Karnataka. Indian J Pathol Microbiol. 2003 Jan;46(1):129-32. PMID 15027755.
Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. The emerging problem of linezolid-resistant staphylococcus. J Antimicrob Chemother. 2013 Jan;68(1):4-11. doi: 10.1093/jac/dks354, PMID 22949625.
Published
How to Cite
Issue
Section
Copyright (c) 2024 VINEELA KODI, JAYAPRADA RANGINENI, YAMINI SHARABU
This work is licensed under a Creative Commons Attribution 4.0 International License.